Antaviro Wound Care Offically Listed in MIMS Malaysia — Advancing Clinical Practice and Community Care
Ionic Global is pleased to share that Antaviro Wound Care Dressing Solution has been officially listed in the MIMS Drug Reference Malaysia (March 2026 Issue, pg. 325) under Surgical Dressings & Wound Care. This milestone reflects increasing clinical recognition of hypochlorous acid (HOCl)–based solutions in modern wound management.
Clinical Relevance in Wound Management
Effective wound healing begins with proper wound bed preparation. One of the key challenges faced by healthcare professionals is the presence of biofilm, microbial load, and necrotic debris, which can significantly delay healing and increase the risk of infection.
Antaviro Wound Care is formulated with Hypochlorous Acid (HOCl), offering:
- Broad-spectrum antimicrobial activity
- Effective removal of debris and microorganisms
- Support for biofilm and slough disruption
- Tissue-compatible, non-cytotoxic wound cleansing
Its mechanism aligns with current wound care principles — creating a clean wound environment to support healing progression and improve clinical outcomes.
Antaviro is suitable for:
- Acute wounds
- Chronic wounds (e.g., diabetic ulcers, pressure injuries)
- Infected or high-risk wounds
From Clinical Application to Real-World Impact
Beyond clinical settings, Antaviro has also been deployed in community care initiatives, where timely and effective wound management is critical.
CSR Case: Supporting Flood-Affected Patients in Hatyai
During a recent flood relief initiative, Ionic Global partnered with local organisations to provide Antaviro Wound Care to patients suffering from untreated and infection-prone wounds due to prolonged exposure to contaminated water.
Before
Many patients presented with:
- Contaminated wounds with visible debris
- Signs of microbial burden and early infection
- Delayed access to proper wound cleansing solutions
Without early intervention, these conditions could escalate into more serious complications.
After (With Wound Cleansing Support)
With consistent use of Antaviro as part of wound cleansing:
- Wound beds were visibly cleaner
- Reduction in debris and surface contaminants
- Improved conditions for subsequent wound care management
- Better tolerance due to non-irritating formulation
While Antaviro is not a standalone treatment, its role in initial wound cleansing and preparation proved valuable in supporting frontline care efforts.
Bridging Clinical Science and Community Needs
The inclusion of Antaviro in MIMS not only reflects its clinical relevance, but also reinforces Ionic Global’s commitment to delivering solutions that extend beyond hospitals into real-world care environments.
As the demand for safe, effective, and tissue-friendly antimicrobial solutions continues to grow, HOCl-based technologies like Antaviro are becoming increasingly important in both clinical protocols and humanitarian applications.
Looking Forward
Ionic Global remains dedicated to advancing wound care through:
- Science-driven formulation
- Clinical alignment
- Meaningful community impact
Antaviro Wound Care — Supporting Better Healing, From Clinics to Communities.